
A new drug shows promise against respiratory virus, study shows
CNN
A new antiviral medication against respiratory syncytial virus, or RSV, appears to be safe and lowered viral levels and symptoms significantly more than a placebo, according to the results of a study published Wednesday in The New England Journal of Medicine.
The study is unusual in that it is based on a two-part human challenge trial, where researchers purposefully infect people with a pathogen to test a new therapy. Challenge studies speed up research because scientists don't have to wait for their study participants to get sick out in the real world. They can also enroll fewer people, knowing that participants will inevitably catch a germ. But they're also risky and only considered ethical when the need for a new treatment or therapy is thought to outweigh the potential risks to study participants.
A winter virus that inundates pediatricians

Two top House lawmakers emerged divided along party lines after a private briefing with the military official who oversaw September’s attack on an alleged drug vessel that included a so-called double-tap strike that killed surviving crew members, with a top Democrat calling video of the incident that was shared as part of the briefing “one of the most troubling things” he has seen as a lawmaker.

Authorities in Colombia are dealing with increasingly sophisticated criminals, who use advanced tech to produce and conceal the drugs they hope to export around the world. But police and the military are fighting back, using AI to flag suspicious passengers, cargo and mail - alongside more conventional air and sea patrols. CNN’s Isa Soares gets an inside look at Bogotá’s war on drugs.

As lawmakers demand answers over reports that the US military carried out a follow-up strike that killed survivors during an attacked on an alleged drug boat in the Caribbean, a career Navy SEAL who has spent most of his 30 years of military experience in special operations will be responsible for providing them.










